from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2361c/-

LFCtreatmentdescriptionclass of inhibitor

-0.838

Amikacinug/mL Amikacintranslation

-0.232

Cap5-10ug/mL Capreomycintranslation

-0.348

Rox10-50 ug/mL Roxithromycintranslation

-0.441

SM2-5 ug/mL Streptomycintranslation

-2.099

Tet5-10 ug/mL Tetracyclinetranslation

1.312

Rif0.2-5ug/mL Rifampicintranscription

-0.054

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.684

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.136

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.205

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.953

Clofazimine10-13 ug/mL Clofaziminerespiration

0.490

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.282

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.316

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.703

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.187

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.496

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.085

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.736

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.303

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.500

KCN5-20 ug/mL Potassium cyaniderespiration

-0.042

NaN30.2-2 mM Sodium aziderespiration

0.230

Nigericin50 uM Nigericinrespiration

-0.805

TRC10-150 ug/mL Triclosanrespiration

-0.691

TRZ10-25 ug/mL Thioridazinerespiration

-1.319

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.387

menadione6-10 ug/mL Menadionerespiration

-1.024

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.188

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.183

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.052

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.721

NRP_1Non-replicating persistence stage 1dosRassociated

0.416

Amp0.2mg/mL AmpicillincellWall

0.104

Cephalexin20-100 ug/mL CephalexincellWall

0.330

Cerulenin0.32-5 ug/mL CerulenincellWall

0.691

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.471

EMB10-20 ug/mL EthambutolcellWall

0.351

Eta12-40 ug/mL EthionamidecellWall

0.387

INH0.2-0.4 ug/mL IsoniazidcellWall

0.088

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.830

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.163

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.286

BZA0.12 mg/mL BenzamidearomaticAmides

-0.031

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.044

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.169

H2O24 mM hydrogen peroxideDNAdamaging

0.585

Levo10 ug/mL LevofloxacinDNAdamaging

0.174

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.366

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.496

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.411

UVUV-irradiationDNAdamaging

-0.292

ARP41-4 ug/mL Antitubercular compound ARP4?

0.028

Antimycin12.5-50 ug/mL Antimycin A?

0.435

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.457

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.745

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.626

PA8240.2-2 ug/mL PA-824?

0.040

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.056

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.253

Verapamil50 uM Verapamil?

-0.147

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.019

methoxatin10-20 ug/mL Methoxatin?